Translational neuroscience and magnetic-resonance microscopy

Lancet Neurology

Volumn 5, Issue 6, 2006, Pages 536-544

  Benveniste, Helene ^a,b   Blackband, Stephen J ^c,d  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d FLORIDA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ANESTHESIA; FUNCTIONAL MAGNETIC RESONANCE IMAGING; IN VIVO STUDY; MICROSCOPY; MONITORING; MORPHOLOGY; NEUROLOGIC DISEASE; NEUROSCIENCE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; RODENT;

ANIMALS; BRAIN DISEASES; DISEASE MODELS, ANIMAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MICE; NEUROSCIENCES; RATS;

EID: 33646535449     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(06)70472-0     Document Type: Review

References (75)

1. Kucharczyk J., Mintorovitch J., Asgari H., and Moseley M. Diffusion/perfusion MR imaging of acute cerebral ischemia. Magn Reson Med 19 (1991) 311-315
2. Gill R., Sibson N., Hatfield R., et al. A comparison of the early development of ischaemic damage following permanent middle cerebral artery occlusion in rats as assessed using magnetic resonance imaging and histology. J Cereb Blood Flow Metab 15 (1995) 1-11
3. Minematsu K., Li L., Sotak C., Davis M., and Fisher M. Reversible focal ischemic injury demonstrated by diffusion-weighted magnetic resonance imaging in rats. Stroke 23 (1992) 1304-1310
4. Verheul H., Berkelbach van der Sprenkel J., Tulleken C., Tamminga K., and Nicolay K. Temporal evolution of focal cerebral ischemia in the rat assessed by T2-weighted and diffusion-weighted magnetic resonance imaging. Brain Topogr 5 (1992) 171-176
5. Lo E., Matsumoto K., Pierce A., Garrido L., and Luttinger D. Pharmacologic reversal of acute changes in diffusion-weighted magnetic resonance imaging in focal cerebral ischemia. J Cereb Blood Flow Meatb 14 (1994) 597-603
6. Reith W., Hasegawa Y., Latour L., et al. Multislice diffusion mapping for 3-D evolution of cerebral ischemia in a rat stroke model. Neurology 45 (1995) 172-177
7. Roussel S., van Bruggen N., King M., et al. Monitoring the initial expansion of focal ischaemic changes by diffusion-weighted MRI using a remote controlled method of occlusion. NMR Biomed 7 (1994) 21-28
8. Steinberg G., Kunis D., DeLaPaz R., and Poljak A. Neuroprotection following focal cerebral ischaemia with the NMDA antagonist dextromethorphan, has a favourable dose response profile. Neurol Res 15 (1993) 174-180
9. Tyszka J., Fraser S., and Jacobs R. Magnetic resonance microscopy: recent advances and applications. Curr Opin Biotechnol 16 (2005) 93-99
10. Pautler R. Mouse MRI: concepts and applications in physiology. Physiology (Bethesda) 19 (2004) 168-175
11. Pirko I., Fricke S., Johnson A., Rodriguez M., and Macura S. Magnetic resonance imaging, microscopy, and spectroscopy of the central nervous system in experimental animals. NeuroRx 2 (2005) 250-264
12. Henkelman R., Chen X., and Sled J. Disease phenotyping: structural and functional readouts. Prog Drug Res 62 (2005) 151-184
13. Fu R., Brey W., Shetty K., et al. Ultra-wide bore 900 MHz high-resolution NMR at the national high magnetic field laboratory. J Magn Reson 177 (2005) 1-8
14. Thulborn K. 9.4T. in International Society of Magnetic Resoance in Medicine 2005.
15. Feder T. Issues and events: lab weds brain research and physics. Phys Today (April 2005) 26
16. Aiken N., Hsu E., and Blackband S. A review of NMR microimaging studies of single cells. J Magn Reson Anal 1 (1995) 41-48
17. Poemer P., Edelstein W., Hayes C., Souza S., and Mueller O. The NMR phased array. Magn Reson Med 16 (1990) 192-225
18. Benveniste H., and Blackband S. MR microscopy and high resolution small animal MRI: applications in neuroscience research. Prog Neurobiol 67 (2002) 393-420
19. Benveniste H., Mareci T., and Blackband S. Anatomical studies in the rodent brain and spinal cord: Applications of magnetic resonance microscopy. In: van Bruggen N., and Roberts T. (Eds). Techniques of biomedical imaging in neuroscience (2003), CRC Press
20. Bell J., and Taylor-Robinson S. Assesing gene expression in vivo: magnetic resonance imaging and spectroscopy. Gene Ther 7 (2000) 1259-1264
21. Lanza G., Winther P., Caruthers S., et al. Magnetic resonance molecular imaging with nanoparticles. J Nucl Cardiol 11 (2004) 733-743
22. Delikatny E., and Poptani H. MR techniques for in vivo molecular and cellular imaging. Radiol Clin North Am 43 (2005) 205-220
23. Koretsky A. New developments in magnetic resonance imaging of the brain. NeuroRx 1 (2004) 155-164
24. Lahti K., Ferris C., Li F., Sotak C., and King J. Comparison of evoked cortical activity in conscious and propofol-anesthetized rats using functional MRI. Magn Reson Med 41 (1999) 412-416
25. Sicard K., Shen Q., Brevard M., et al. Regional cerebral blood flow and BOLD responses in conscious and anesthetized rats under basal and hypercapnic conditions: implications for functional MRI studies. J Cereb Blood Flow Metab 23 (2003) 472-481
26. Baslow M., Dyakin V., Nowak K., Hungund B., and Guilfoyle D. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia. J Mol Neurosci 26 (2005) 1-16
27. Gozzi A., Schwarz A., Reese T., et al. Functional magnetic resonance mapping of intracerebroventricular infusion of a neuroactive peptide in the anaesthetised rat. J Neurosci Methods 142 (2005) 115-124
28. Marota J., Mandeville J., Weisskoff R., et al. Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat. Neuroimage 11 (2000) 13-23
29. Shaw N. The effects of chloralose on the brainstem auditory evoked potential of the rat. Neuropharmacology 29 (1990) 561-565
30. Helfaer M., Kirsch J., and Traystman R. Anesthetic modulation of cerebral hemodynamic and evoked responses to transient middle cerebral artery occlusion in cats. Stroke 21 (1990) 795-800
31. Gyngell M., Bock C., Schimtz B., Hoehn-Berlage M., and Hossmann K. Variation of functional MRI signal in response to frequency of somatosensory stimulation in alpha chloralose anesthetized ratas. Magn Reson Med 36 (1996) 13-15
32. Silva A., and Koretsky A. Laminar specificity of fMRI onset times during somatosensory stimulation in the rat. Proc Natl Acad Sci USA 99 (2002) 15182-15187
33. Hyder F., Bhehar K., Martin M., Blamire A., and Shulman R. Dynamic magnetic resonance imaging of the rat brain during forepaw stimulation. J Cereb Blood Flow Metab 14 (1994) 649-655
34. Huang W., Plyka I., Li H., Eisenstein E., et al. Magnetic resonance imaging (MRI) detection of the murine brain response to light: temporal differentiation and negative functional MRI changes. Proc Natl Acad Sci USA 93 (1996) 6037-6042
35. Devor A., Ulbert I., Dunn A., et al. Coupling of the cortical hemodynamic response to cortical and thalamic neuronal activity. Proc Natl Acad Sci USA 102 (2005) 3822-3827
36. Tuor U., Malisza K., Foniok T., et al. Functional magnetic resonance imaging in rats subjected to intense electrical and noxious chemical stimulation of the forepaw. Pain 87 (2000) 315-324
37. Febo M., Segarra A., Nair G., et al. The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 30 (2005) 936-943
38. Mano I., Levy R., Crooks L., and Hosobuchi Y. Proton nuclear magnetic resonance imaging of acute experimental cerebral ischemia. Invest Radiolo 18 (1983) 345-351
39. Hedlund L., Cofer G., Owen S., and Allan Johnson G. MR-compatible ventilator for small animals: computer-controlled ventilation for proton and noble gas imaging. Magn Reson Imaging 18 (2000) 753-759
40. Hedlund L., Deitz J., Nassar R., et al. A ventilator for magnetic resonance imaging. Invest Radiol 21 (1986) 18-23
41. Klaunberg B., and Lizak M. Considerations for setting up a small-animal imaging facility. Lab Anim (NY) 33 (2004) 28-34
42. Zhan H., Tada T., Fujikura E., et al. A container for transporting small laboratory animals for magnetic resonance imaging. J Neurosci Methods 144 (2005) 143-146
43. Braun A., Wheeler C., Hedlund L., and Johnson G. Fiber-optic stethoscope:A cardiac monitoring and gating system for magnetic resonance microscopy. Magn Reson Med 47 (2002) 314-321
44. Dazai J., Bock N., Nieman B., et al. Multiple mouse biological loading and monitoring system for MRI. Magn Reson Med 52 (2004) 709-715
45. Sowell E., Thompson P., Welcome S., et al. Cortical abnormalities in children and adolescents with attention-deficit hyperactivity disorder. Lancet 362 (2003) 1699-1707
46. Zang da W., Yang Q., Wang H., et al. Magnetic resonance imaging reveals neuronal degeneration in the brainstem of the superoxide dismutase 1 transgenic mouse model of amyotrophic lateral sclerosis. Eur J Neurosci 20 (2004) 1745-1751
47. Yu O., Steibel J., Mauss Y., et al. Remyelination assessment by MRI texture analysis in a cuprizone mouse model. Magn Reson Imaging 22 (2004) 1139-1144
48. Mueggler T., Meyer-Luehmann M., Rausch M., et al. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis. Eur J Neurosci 20 (2004) 811-817
49. Wainwright M., Craft J., Griffin W., et al. Increased susceptibility of S100B transgenic mice to perinatal hypoxia-ischemia. Ann Neurol 56 (2004) 61-67
50. Ten V., Wu E., Tang H., et al. Late measures of brain injury after neonatal hypoxia-ischemia in mice. Stroke 35 (2004) 2183-2188
51. Magnitsky S., Watson D., Walton R., et al. In vivo and ex vivo MRI detection of localized and disseminated neural stem cell grafts in the mouse brain. Neuroimage 26 (2005) 744-754
52. Dunn J., and Zaim-Wadghiri Y. Quantitative magnetic resonance imaging of the mdx mouse model of Duchenne muscular dystrophy. Muscle Nerve 22 (1999) 1367-1371
53. Utriainen A., Sormunen R., Kettunen M., et al. Structurally altered basement membranes and hydrocephalus in a type XVIII collagen deficient mouse line. Hum Mol Genet 13 (2004) 2089-2099
54. Qi X., Lewin A., Sun L., Hauswirth W., and Guy J. SOD2 gene transfer protects against optic neuropathy induced by deficiency of complex I. Ann Neurol 56 (2004) 182-191
55. McDaniel B., Sheng H., Warner D., Hedlund L., and Benveniste H. Tracking brain volume changes in C57BL/6J and ApoE-deficient mice in a model of neurodegeneration: a 5-week longitudinal micro-MRI study. Neuroimage 14 (2001) 1244-1255
56. Lynch J., Pineda J., Morgan D., et al. Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema. Ann Neurol 51 (2002) 113-117
57. Spires T., and Hyman B. Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2 (2005) 423-437
58. Nordberg A. PET imaging of amyloid in Alzheimer's disease. Lancet Neurol 3 (2004) 519-527
59. Ono M., Yoshida N., Ishibashi K., et al. Radioiodinated flavones for in vivo imaging of beta-amyloid plaques in the brain. J Med Chem 48 (2005) 7253-7260
60. Toyama H., Ye D., Ichise M., et al. PET imaging of brain with the beta-amyloid probe, [11C]6-OH-BTA-1, in a transgenic mouse model of Alzheimer's disease. Eur J Nucl Med Mol Imaging 32 (2005) 593-600
61. Wang Y., Klunk W., Debnath M., et al. Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease. J Mol Neurosci 24 (2004) 55-62
62. Zhang W., Oya S., Kung M., et al. F-18 Polyethyleneglycol stilbenes as PET imaging agents targeting Abeta aggregates in the brain. Nucl Med Biol 32 (2005) 799-809
63. Zhang W., Oya S., Kung M., et al. F-18 stilbenes as PET imaging agents for detecting beta-amyloid plaques in the brain. J Med Chem 48 (2005) 5980-5988
64. Higuchi M., Iwata N., Matsuba Y., et al. 19F and 1H MRI detection of amyloid beta plaques in vivo. Nat Neurosci 8 (2005) 527-533
65. Redwine J., Kosofsky B., Jacobs R., et al. Dentate gyrus volume is reduced before onset of plaque formation in PDAPP mice: a magnetic resonance microscopy and stereologic analysis. Proc Natl Acad Sci USA 100 (2003) 1381-1386
66. Albert M. Cognitive and neurobiologic markers of early Alzheimer disease. Proc Natl Acad Sci USA 93 (1996) 13547-13551
67. Zhang L., Kim K.-R., Bales K., Paul S.-M., and Benveniste H. Tracking of pathology in PDAPP mice by MRI: a two-year longitudinal study. Abstr Soc Neurosci Program No. 572.14 27 (2001)
68. Ma Y., Hof P., Grant S., et al. A Three-dimensional digital atlas database of the adult C57B/6J Mouse brain by magnetic resonance microscopy. Neuroscience 135 (2005) 1203-1215
69. Kovacevic N., Henderson J., Chan E., et al. A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. Cereb Cortex 15 (2005) 639-645
70. Rubins D., Melega W., Lacan G., et al. Development and evaluation of an automated atlas-based image analysis method for microPET studies of the rat brain. Neuroimage 20 (2003) 2100-2118
71. Bock N., Nieman B., Bishop J., and Mark Henkelman R. In vivo multiple-mouse MRI at 7 Tesla. Magn Reson Med 54 (2005) 1311-1316
72. Dijkhuizen R., Singhal A., Mandeville J., et al. Correlation between brain reorganization, ischemic damage, and neurologic status after transient focal cerebral ischemia in rats: a functional magnetic resonance imaging study. J Neurosci 23 (2003) 510-517
73. Yu X., Wadghiri Y., Sanes D., and Turnbull D. In vivo auditory brain mapping in mice with Mn-enhanced MRI. Nat Neurosci 8 (2005) 961-968
74. Lee J., Silva A., Merkle H., and Koretsky A. Manganese-enhanced magnetic resonance imaging of mouse brain after systemic administration of MnCl2: dose-dependent and temporal evolution of T1 contrast. Magn Reson Med 53 (2005) 640-648
75. Pautler P., Silva A., and Koretsky A. In vivo neuronal tract tracing using manganese-enhanced magnetic resonance imaging. Magn Reson Med 70 (1998) 740-748